BridgeBio Pharma Inc (BBIO) kicked off at the price of $43.5: Venture capitalists have an exciting new opportunity

BridgeBio Pharma Inc (NASDAQ: BBIO) kicked off on Monday, down -1.11% from the previous trading day, before settling in for the closing price of $43.99. Over the past 52 weeks, BBIO has traded in a range of $21.72-$45.48.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

During the last 5-year period, the sales drop of Healthcare Sector giant was -3.04%. While this was happening, its average annual earnings per share was recorded -1.36%. With a float of $160.86 million, this company’s outstanding shares have now reached $189.83 million.

Let’s determine the extent of company efficiency that accounts for 730 employees. In terms of profitability, gross margin is 96.95%, operating margin of -547.57%, and the pretax margin is -528.55%.

BridgeBio Pharma Inc (BBIO) Breakdown of a Key Holders of the stock

Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of BridgeBio Pharma Inc is 15.28%, while institutional ownership is 83.87%. The most recent insider transaction that took place on Jul 02 ’25, was worth 1,709,050. In this transaction Chief Executive Officer of this company sold 40,000 shares at a rate of $42.73, taking the stock ownership to the 955,686 shares. Before that another transaction happened on Jul 01 ’25, when Company’s Chief Executive Officer sold 40,000 for $42.54, making the entire transaction worth $1,701,400. This insider now owns 975,686 shares in total.

BridgeBio Pharma Inc (BBIO) Recent Fiscal highlights

According to the Wall Street analysts, stocks earnings will be around -1.36% per share during the next fiscal year.

BridgeBio Pharma Inc (NASDAQ: BBIO) Trading Performance Indicators

Take a look at BridgeBio Pharma Inc’s (BBIO) current performance indicators. Last quarter, stock had a quick ratio of 4.54. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 64.82.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.53, a number that is poised to hit -0.76 in the next quarter and is forecasted to reach -1.61 in one year’s time.

Technical Analysis of BridgeBio Pharma Inc (BBIO)

Looking closely at BridgeBio Pharma Inc (NASDAQ: BBIO), its last 5-days average volume was 3.18 million, which is a jump from its year-to-date volume of 3.09 million. As of the previous 9 days, the stock’s Stochastic %D was 58.30%.

During the past 100 days, BridgeBio Pharma Inc’s (BBIO) raw stochastic average was set at 88.45%, which indicates a significant increase from 66.15% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 39.20% in the past 14 days, which was lower than the 49.68% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $37.91, while its 200-day Moving Average is $31.81. However, in the short run, BridgeBio Pharma Inc’s stock first resistance to watch stands at $43.86. Second resistance stands at $44.23. The third major resistance level sits at $44.68. If the price goes on to break the first support level at $43.04, it is likely to go to the next support level at $42.59. Now, if the price goes above the second support level, the third support stands at $42.22.

BridgeBio Pharma Inc (NASDAQ: BBIO) Key Stats

The company with the Market Capitalisation of 8.26 billion has total of 189,881K Shares Outstanding. Its annual sales at the moment are 221,900 K in contrast with the sum of -535,760 K annual income. Company’s last quarter sales were recorded 116,630 K and last quarter income was -167,420 K.

News Daemon
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.